7, 1Ј-CH2), 3.45–3.56 (2H, br res, 3Ј-CH2), 7.15–7.29 (2H, m,
5- and 6-H), 7.81 (1H, dd, J 6.5 and 2.9, 4-H) and 9.05–9.23
(1H br s, NH); δC (330 K) 26.0 (CH2), 28.4 (C(CH3)3), 34.2, 61.7
(both CH2), 84.0 (C(CH3)3), 118.6, 125.2 (both CH), 125.3 (C),
129.5 (CH), 145.6 (C) and 154.3 (CO); m/z 293 (Mϩ ϩ H,
100%) and 237 (45).
5- and 6-H), 7.82–7.90 (1H, br res, 4-H) and 9.34–9.56 (1H, br s,
NH); δC 25.5 (2Ј-CH2), 28.5 (C(CH3)3), 29.6 (2 × CH3), 45.5
(1Ј-CH2), 71.5 (3Ј-C), 83.9 (C(CH3)3), 118.4, 125.2 (both CH),
126.4 (C), 129.1 (CH), 131.2, 145.0 (C) and 154.3 (CO); m/z 321
(Mϩ ϩ H, 100%) [Found: Mϩ ϩ H, 321.1927. C16H25N4O3
requires M, 321.1927].
8-Iodochromane 35a
2,2-Dimethyl-8-iodochromane 35c
By the general deprotection procedure followed by direct treat-
ment of the dichloromethane solution resulting from work-up
with NIS, the foregoing hydroxypropylbenzotriazole 34a (80
mg, 0.27 mmol) was converted into 8-iodochromane 35a (61 mg,
86%), a yellow solid, mp 101–102 ЊC, νmax/cmϪ1 3062, 3026,
2984, 2933, 1495, 1450, 1371, 1226, 1146, 1017, 814, 738 and
699; δH 1.90–1.97 (2H, m, 3-CH2), 2.71 (2H, app t, J 6.5,
4-CH2), 4.18–4.22 (2H, m, 2-CH2), 6.50 (1H, app t, J 7.6, 6-H),
6.92 (1H, dd, J 7.5 and 1.3, 5(7)-H) and 7.51 (1H, dd, J 8.3 and
1.2, 7(5)-H); δC 21.2, 24.2, 66.6 (all CH2), 84.4 (8-CI), 120.7
(CH), 122.2 (C), 129.0, 136.0 (both CH) and 152.6 (C); m/z (EI)
260 (Mϩ, 81%), 127 (96) and 105 (100) [Found: Mϩ, 259.9695.
C9H9IO requires M, 259.9700].
The foregoing N-Boc benzotriazole 34c (0.30 g, 0.95 mmol) was
deprotected using the general procedure to give an intermediate
amino alcohol (0.19 g, 92%) as an orange oil, νmax/cmϪ1 3341,
2074, 1674, 1373 and 1166; δH 1.24 (6H, s, 2 × CH3), 1.83–1.90
(2H, m, 2Ј-CH2), 3.19–3.24 (2H, m, 1Ј-CH2), 6.62–6.75 (2H, br
s, NH2), 7.11–7.32 (2H, m, 5- and 6-H) and 7.72 (1H, d, J 8.2,
4-H); δC 25.9 (2Ј-CH2), 29.2 (2 × CH3), 45.5 (1Ј-CH2), 73.0
(3Ј-C), 116.8, 126.5 (both CH), 127.8 (C), 129.3 (CH), 130.9
and 143.3 (both C).
Without further characterization, the foregoing amino-
alcohol (0.39 g, 1.78 mmol) was treated with NIS, as described
in the general procedure, to give the 2,2-dimethyl-8-iodo-
chromane 35c (0.45 g, 90%) as a yellow solid, mp 95–97 ЊC
[Found: C, 45.93; H, 4.76. C11H13IO requires C, 45.83; H,
4.55%], νmax/cmϪ1 3015, 2975, 2926, 2848, 1559, 1440, 1370,
1256, 1219, 1157 and 1120; δH 1.40 (6H, s, 2 × CH3), 1.83 (2H, t,
J 6.7, 3-CH2), 2.79 (2H, t, J 6.7, 4-CH2), 6.60 (1H, t, J 7.7, 6-H),
7.05 (1H, d, J 7.7, 7-H) and 7.61 (1H, d, J 7.7, 5-H); δC 23.2
(3-CH2), 27.4 (2 × CH3), 33.3 (4-CH2), 76.4 (2-C), 86.9 (8-CI),
121.6 (CH), 122.3 (C), 130.0, 137.5 (both CH) and 153.5 (C);
m/z (EI) 288 (Mϩ, 50%), 232 (53) and 127 (100) [Found: Mϩ,
288.0036. C11H13IO requires M, 288.0013].
1-Amino-7-(3Ј-hydroxypentan-1Ј-yl)benzotriazole 34b
Hydrogenation of the acetylenic alcohol 33b (0.26 g, 0.82
mmol) by the general procedure gave 1-(tert-butoxycarbonyl-
amino)-7-(3Ј-hydroxypentan-1Ј-yl)benzotriazole 34b (0.25 g,
96%) as an orange oil, δH 0.89 (3H, br t, J ca. 6, 5Ј-CH3), 1.25–
1.60 (11H, m, 4Ј-CH2 and But), 1.72 (2H, br quintet, J ca. 6, 2Ј-
CH2), 2.95–3.15 (2H, br res, 1Ј-CH2), 3.40–3.55 (1H, br res,
CHOH), 7.19–7.26 (2H br res, 5- and 6-H), and 7.72–7.86 (1H,
br res, 4-H). Without further purification or characterization,
the sample was subjected to the general deprotection procedure
to give the corresponding aminoalcohol (0.14 g, 84%) as an
orange oil, νmax/cmϪ1 3344, 2933, 2876, 1640, 1603, 1504, 1456,
1370, 1252, 1168 and 1121; δH 0.91 (3H, t, J 7.4, 5Ј-CH3), 1.51
(2H, quintet, J 7.4, 4Ј-CH2), 1.86 (2H, m, 2Ј-CH2), 2.45–2.52
(1H, br s, OH), 3.28 (2H, t, J 8.1, 1Ј-CH2), 3.51–3.57 (1H, m,
3Ј-CHOH), 6.12 (2H, br s, NH2), 7.11–7.23 (2H, m, 5- and 6-H)
and 7.76–7.82 (1H, m, 4-H); δC 8.9 (5Ј-CH3), 25.4, 29.2, 37.7
(all CH2), 71.1 (3Ј-CH), 116.3, 123.4 (both CH), 125.6 (C),
127.0 (CH), 131.0 and 143.9 (both C); m/z 221 (Mϩ ϩ H, 100%)
[Found: Mϩ ϩ H, 221.1404. C11H17N4O requires M, 221.1402].
1-(tert-Butoxycarbonylamino)-7-(3Ј,4Ј-dihydroxy-3Ј-methyl-
butan-1Ј-yl)benzotriazole 34f
Benzotriazole 33f (0.24 g, 0.72 mmol) was hydrogenated using
the general procedure to give the diol 34f (0.22 g, 92%) as a
colourless solid, mp 132–135 ЊC [Found: C, 55.54; H, 6.94; N,
16.28. C16H24N4O4 requires C, 57.11; H, 7.19; N, 16.66%], νmax
/
cmϪ1 3350, 2979, 1740, 1440, 1376, 1255, 1159 and 773; δH (333
K) 1.30 (3H, s, 3Ј-CH3), 1.50 (9H, s, But), 1.83–1.90 (2H, m,
2Ј-CH2), 3.04–3.11 (2H, m, 1Ј-CH2), 3.52 (1H, d, J 10.9, 4Ј-Ha),
3.60 (1H, d, J 10.9, 4Ј-Hb), 7.32 (2H, m, 5- and 5-H) and 7.89–
7.96 (1H, m, 4-H); m/z 337 (Mϩ ϩ H, 100%) and 279 (57)
[Found: Mϩ ϩ H, 337.1876. C16H25N4O4 requires M, 337.1876].
2-Ethyl-8-iodochromane 35b
(8-Iodo-2-methylchroman-2-yl)methanol 35f
The foregoing 1-aminobenzotriazole, derived from benzo-
triazole 34b (0.36 g, 1.63 mmol) was treated with NIS, as
described in the general procedure, to give the 2-ethyliodo-
chromane 35b (0.40 g, 85%) as a yellow solid, mp 107–109 ЊC;
νmax/cmϪ1 2955, 2923, 2848, 1638, 1449, 1373, 1237, 1108, 1072
and 757; δH 0.98 (3H, t, J 6.0, CH3CH2), 1.72–1.89 (3H, m, 3-Ha
and CH3CH2), 2.01 (1H, dddd, J 13.6, 8.6, 5.4 and 2.6, 3-Hb),
2.73 (1H, dd, J 16.6, 5.5 and 5.4, 4-Ha), 2.85 (1H, ddd, J 16.6,
11.0 and 5.5, 4-Hb), 3.99 (1H, dddd, J 10.2, 7.7, 2.6 and 2.5,
2-H), 6.58 (1H, t, J 7.7, 6-H), 7.00 (1H, d, J 7.7, 7-H) and 7.56
(1H, d, J 7.7, 5-H); δC 10.4 (CH3), 25.4, 27.5, 28.7 (all CH2),
78.9 (2-CH), 86.4 (8-CI), 121.9 (CH), 123.2 (C), 130.0, 137.3
(both CH) and 152.3 (C); m/z (EI) 288 (Mϩ, 100%) and 233 (80)
[Found: Mϩ, 288.0011. C11H13IO requires M, 288.0013].
By the combined deprotection and cyclisation procedures in
which the intermediate 1-aminobenzotriazole was not isolated,
the foregoing diol 34f (0.354 g, 1.05 mmol) was converted into
the 8-iodochromanylmethanol 35f (0.25 g, 78%) as a beige oil,
νmax/cmϪ1 3418, 2955, 2931, 2924, 1442, 1374, 1238, 1153, 1054
and 763; δH 1.37 (3H, s, 2-CH3), 1.75 (1H, ddd, J 13.7, 6.2 and
4.2, 3-Ha), 1.97 (1H, ddd, J 13.7, 11.1 and 6.0, 3-Hb), 2.77 (1H,
ddd, J 16.6, 6.2 and 6.0, 4-Ha), 2.86 (1H, ddd, J 16.6, 11.1 and
4.2, 4-Hb), 3.61 (1H, d, JAB 9.7, 1Ј-Ha), 3.64 (1H, d, JAB 9.7,
1Ј-Hb), 6.64 (1H, t, J 7.7, 6-H), 7.11 (1H, d, J 7.7, 7-H) and 7.64
(1H, d, J 7.7, 5-H); δC 21.1 (2-CH3), 22.1, 28.3 (3- and 4-CH2),
69.7 (CH2OH), 79.0 (2-C), 86.8 (8-CI), 122.2 (CH), 122.9 (C),
130.0, 137.4 (both CH) and 152.4 (C); m/z (EI) 304 (Mϩ, 42%),
273 (84), 146 (36), 131 (61), 105 (93) and 77 (100) [Found:
Mϩ, 303.9951. C11H13IO2 requires M, 303.9962].
1-(tert-Butoxycarbonylamino)-7-(3Ј-hydroxy-3Ј-methylbutan-1Ј-
yl)benzotriazole 34c
(Z)-1-(tert-Butoxycarbonylamino)-7-(3Ј-hydroxyprop-1Ј-en-1Ј-
yl)benzotriazole 40a
The acetylenic alcohol 33c (0.54 g, 1.71 mmol), derived from
2-methylbut-3-yn-2-ol, was subjected to the general hydrogen-
ation procedure to give the 3Ј-hydroxybutylbenzotriazole 34c
(0.52 g, 95%) as an orange oil, νmax/cmϪ1 3288, 2973, 1748, 1459,
1370, 1276, 1254, 1159 and 773; δH 1.27–1.34 (6H, app br s,
2 × CH3), 1.35–1.61 (9H, br s, But), 1.79–1.82 (2H, br res,
2Ј-CH2), 3.06–3.15 (2H, br res, 1Ј-CH2), 7.25–7.32 (2H, br res,
Benzotriazole 33a (0.10 g, 0.34 mmol), derived from propar-
gylic alcohol, in methanol (1 ml) was added to a suspension of
10% palladium on charcoal (0.05 g) in methanol (5 ml) contain-
ing quinoline (10 µl). The resulting mixture was stirred vigor-
ously under an atmosphere of hydrogen for 2 h, then the
J. Chem. Soc., Perkin Trans. 1, 2000, 2343–2355
2353